Max International ANNOUNCES its Unique and Unparalleled Medical Advisory Board

While most pharmaceutical and nutriceutical companies have medical advisory boards, to our knowledge, NONE have one like that of Max International. The uniqueness of Max's medical advisory board begins with the diversity of its members. It is rare that such a board is made up of members representing such diverse medical and scientific disciplines. For example the board includes the current dean of a college of pharmaceutical sciences at a renowned university, a world renowned pathologist, a heart surgeon, and orthopedic surgeon, two ob/gyns, an immunologist, a pediatrician, medical school professors and other premier medical professionals. Even more astonishing, Max's medical advisory board members receive no financial compensation for being on our board. The doctors, scientists and educators on our advisory board are participating for one reasonthey believe in our science and the extraordinary breakthrough products that have been and will be developed by our science. It is also important to note that each member of this board uses Max products in their quest for optimal health. As you will see, their achievements and credentials within their respective medical fields are stellar. Their participation on our board is something every Max Associate should be proud of and utilize as they share the Max vision and products with others. Their unpaid participation in our board brings a level of credibility to our science and products that is truly unparalleled in the nutritional world.

Max's Medical Advisory Board

Jeanette

C.

Roberts,

Ph.D.

Medicinal
University University

Chemistry
of of Wisconsin Wisconsin

Dean, School of Pharmacy, The Professor, Pharmaceutical Sciences,

Dr. Roberts received her Ph.D in Pharmaceutical Chemistry from the University of Minnesota in 1986. Dr. Roberts has authored more than 50 peerreviewed articles in various scientific journals. She has served in numerous faculty positions at both the University of Wisconsin and the University of Utah. In addition to her duties as Dean of the School of Pharmacy at the University of Wisconsin, she is also an adjunct professor of Pharmacology and Toxicology and an Adjunct Professor of Medicinal Chemistry for the University of Utah. She has been the recipient of more than one million dollars in study grants from various scientific bodies including NASA, the Cancer Research Foundation of America, and the Armed Forces Radiobiology Research Institute. She has also been awarded numerous patents and a myriad of academic and scientific awards. She has witnessed first hand the extraordinary benefits of Max International's RiboCeine, as she participated in fifteen published studies on RiboCeine conducted over a period of nineteen years (from 1985 and 2004).

Douglas S. Harrington M.D., Pathology and Hematology,

FASCP, FCAP

Clinical Associate Professor of Pathology, University of Southern California, Keck School of Medicine. Dr. Harrington currently serves as CEO of Aviir, Inc, a Stanford University spin-out cardiac biomarker company. He holds multiple professional affiliation memberships including the American Medical Association, the American Society of Clinical Pathologists, the College of American Pathologists, the Association for Molecular Pathology and the International Academy of Pathology. Dr. Harrington received his B.A. in Molecular Biology and M.D. from the University of Colorado. He is Board Certified in Anatomic and Clinical Pathology and Hematology and has authored numerous peer-reviewed publications. He is licensed in a number of states including New York where he holds CQ's in Molecular and Biochemical Genetics. Dr. Harrington has taken a number of new molecular technologies (both services and devices) through state and federal regulatory approval. He has multiple

professional affiliations including the American Medical Association and The Association for Molecular Pathology, and has authored over 80 scientific studies and publications. Dr. Harrington has more than twenty-five years of experience in the commercialization of healthcare technologies. Most recently he has created a breakthrough methodology for the accurate prediction of heart attacks and strokes, even among population groups formerly considered to be of no risk to low risk for such events. His company has received extraordinary acclaim and funding from the National Institutes of Health and pharmaceutical companies to advance his program throughout the medical world as quickly as possible. During the past several years, Dr. Harrington witnessed the transformational impact of elevated glutathione levels from Max's products in his own life and the lives of his immediate and extended family members. He now promotes and clinically recommends the use of Max products to everyone who wants to maximize their health and quality of life.

Greg Brevitti, M.D. Cardiovascular Surgeon, FACS., FACC., FACCP.

Assistant Professor of Surgery (Cardiothoracic), The State University of New YorkHealth Sciences Center at Brooklyn. Dr. Brevitti received his M.D. degree from The State University of New York Health Sciences Center at Brooklyn, College of Medicine in 1993. He is a third generation physician after his father and grandfather. He pursued specialization in surgery at The University of Iowa Hospitals and Clinics from 1993 through 1998 and Cardiothoracic Surgery at The University of California-San Francisco from 1998 through 2000. He is a Fellow of the American College of Surgeons, The American College of Cardiology, The American College of Chest Physicians, and a member of the Society of Thoracic Surgeons. Dr. Brevitti is the founder of a large surgical multispecialty group in New York City and the author of numerous peerreviewed scientific articles. Several years ago, Dr. Brevetti reviewed all of the published scientific data on Riboceine and numerous scientific articles on glutathione and disease processes and its role as an antioxidant. He came away with a clear understanding that organized medicine had generally neglected this very important molecule. He became a user of the Max's products both personally and professionally and has been an articulate advocate for Max's RiboCeine powered products ever since.

Rex
Founder,

Anderson
NeuroMedical

Jr.
Institute

M.D.,
for Age

Neurology
Management

Dr. Rex Anderson, Jr. M.D received his medical degree from the University of Texas Medical Branch in Galveston, Texas. After a mixed medicine internship, he completed a residency program in neurology at the University of Utah College of Medicine in Salt Lake City, Utah. Afterward, he spent two years in the armed forces and then established a neurology practice. Throughout his 30 years of neurological practice Dr. Anderson witnessed a large variety of acute neurological and chronic degenerative diseases. He realized the best treatment was prevention. Taking a proactive approach, he founded the NeuroMedical Institute for Age Management in Dallas, focusing on preventing degenerative diseases before they occur. He completed Physician Training & Certification in Age Management Medicine, jointly sponsored by Cenegenics Education and Research Foundation (CERF) and the Foundation for Care Management (FCM). Dr. Anderson became a Cenegenics Medical Institute physician affiliate because of their extensive experience in age management medicine, evidence-based approachs, continued education emphasis as well as their strong insistence on medical excellence and quality patient care. In 2008, he partnered with Cenegenics and Dr. Paul D. Thompson to establish a progressive-edge medical center, Cenegenics Dallas-Ft. Worth. With more than three decades of neurological practice, Dr. Anderson has a particular interest in helping patients maintain the best possible brain function. After studying the science surrounding glutathione enhancement and experiencing the benefits of Max products first hand, Dr. Anderson began recommending Max to his clients. The results he saw were so profound, he decided to require all new clients to begin using Max as a part of their age-management program.

Don Colbert M.D., Family Practice and Integrative Medicine

NY Times Best Selling Author and Medical Director, Divine Health and Wellness Center Don Colbert, M.D. is board certified in family practice and integrative medicine. He is the Medical Director of the Divine Health Wellness Center in Orlando, Florida as well as the Medical Director of Harvest Time International. He is an internationally known expert and prolific speaker on integrative medicine. Dr. Colbert is on the Medical Advisory Board for the Fellowship of Christian Athletes. Dr. Colbert has been featured on Fox News, ABC World News, The Atlanta Journal Constitution, BBC, Readers Digest, News Week, Prevention Magazine, Joyce Meyer, Kenneth Copeland's Believers Voice of Victory, This is Your Day, John Hagee and many others. He is a best-selling author of over 40 books (ten million copies) including The Seven Pillars of Health, Toxic Relief, Deadly Emotions, and Stress Less as

well as the New York Times Best Selling books The Seven Pillars of Health and I Can Do This Diet. He is also the radio host of his syndicated program "Dr Colbert's Health Report." Dr. Colbert has long been a proponent of the critical importance of glutathione enhancement and has used intravenous glutathione treatments with many of his patients. When he began using the oral supplements, MaxGXL and MaxOne, he was shocked by their extraordinary performance. But he stated that Cellgevity has taken glutathione enhancement and nutritional supplementation to a whole new level. In his latest book, he wrote, "Cellgevity is the most powerful anti-aging, detoxifying and anti-inflammatory supplement that I have ever experienced."

Dr.

Rex

Manayan

M.D,

Thoracic

Surgeon

Dr. Manayan earned his medical degree from Tufts University, School of Medicine in Boston, MA in 1991. He completed his General Surgical Training at Swedish Medical Center in Seattle, WA. Dr. Manayan completed a Thoracic Surgery Fellowship at the Bristol Royal Infirmary, England. Prior to medical school, Dr. Manayan received his Bachelor's and Master of Science Degrees in the Biological Sciences from the University of California, San Diego. Dr. Manayan stated in an interview that with Thoracic Surgery often being a matter of life and death, during his long days of surgery, Max enabled him to optimize his energy level and his focus like never before. As he experienced the Max differences in his own life and the lives of his family members, he began offering it to his patients and saw the same kinds of results, almost universally.

Dr. Robert L. Reid, M.D., Orthopedic Surgeon

F.R.C.S.(C)

Dr. Reid graduated from the University of Toronto Medical School in 1963, and completed his residency in Orthopedic Surgery in 1970, becoming a Fellow of the Royal College of Physicians and Surgeons. He was Certified by the American Board of Orthopedic Surgeons in 1972. He maintained a practice in Orthopedic Surgery from 1976 until he reached the Canadian mandatory retirement age for surgeons. His practice then changed to a specialty in pain management, which continues to this day.

Dr.

John

Kindle

M.D.,

Family

Practice

CCFP

Dr. John Kindle M.D. has been a family doctor in active practice for more than 37 years. In the mid 1990's he was the Chief of Palliative Care at the Riverside Hospital in Ottawa Canada and that is when he was first exposed to alternate treatments by his patients who introduced him to nutritional supplements to help their bodies heal. In 2003 Dr. Kindle became a survivor of kidney cancer and this further intensified his interest in prevention and the role of supplements in keeping the individual cells of our bodies healthy. Dr. Kindle began using Max products in 2007 and studied published scientific articles on glutathione and glutathione enhancement. His commitment to Max International continued to grow as he saw the extraordinary outcomes produced by the product in the lives of his clients.

Charles

Mabry,

M.D.

OB/GYN

Dr. Charles Mabray is a graduate of Baylor College of Medicine and a Diplomat and Fellow at the American College of OB/GYN. He is a Diplomat of the American Board of Environmental Medicine and is certified with the American Board of Bariatric Medicine. He has several publications in peerreviewed journals and is the author of a book on nutrition and health, The Genesis Strategy. Dr. Mabray considers himself to be a student of medicine who isn't content to merely diagnose but is always asking how and why. Dr. Mabray said he constantly strives to establish better, less invasive, treatment methods that treat patients using few medications, while trying to raise patient awareness regarding personal responsibility. He is a long-time advocate of nutritional supplements. After his introduction to Max in May of 2007 he began to offer MaxGXL on a small scale to patients, family and friends. "It rapidly became obvious that MaxGXL had something special, yielding quality of life improvement in multiple areas. I am now a full-fledged fan. I would encourage all of my medical friends to get acquainted with the Max line of products."

Dr. Raul Oncology,

Morales-Borges: Angiology

Immunology,
FICPS,

Hemotology,
FISH

FIACATH,

Medical Director, American Red Cross, Blood Services of Puerto Rico Dr. Raul H. Morales-Borges received his Bachelor Degree in Science with a major in Pre Medical Sciences at the University of Puerto Rico in 1985, and Medical Doctor Degree at San Juan Bautista School of Medicine in Caguas, Puerto Rico in 1990. He completed his residency in Internal Medicine at Henry Ford Hospital in Detroit, Michigan in 1993 followed by his fellowship in Hematology and Medical Oncology at Providence Hospital and University of Michigan Medical Center in Michigan in 1995.

He returned to Puerto Rico and has been working as a hematologist and medical oncologist at a solo private practice at the Ashford Medical Center in San Juan, Puerto Rico since the summer of 1995. Dr. Morales Borges is the Medical Director of the American Red Cross, Blood Services from Puerto Rico since December of 2010. He is a former President of the American Cancer Society of Puerto Rico, former Trustee of the Ashford Presbyterian Community Hospital, and former Professor of Immunology, Genetics, and Pathology and Chairman and Trustee of the Board of Trustees of San Juan Bautista School of Medicine. Dr. Morales Borges is a Fellow of Interamerican College of Physicians and Surgeons (FICPS), Fellow of American Society of Angiology (FASA), Fellow of International Society of Hematology (FISH), and Fellow of International Academy of Clinical and Applied Thrombosis and Haemostasis (FIACATH). He is a speaker and member of the advisory board of Sanofi Aventis. He is an active member of the American Association of Blood Banks and American Society for Apheresis.

Jack

H.

Tarr,

M.D

Founder and President, Family Care Specialists, Knoxville, TN. Dr. Jack Tarr has been a physician for 34 years and has been named by his peers as one of Knoxville's Top Doctors. He is the founding physician and President of a 10 provider medical group, Family Care Specialists, which sees over 70,000 patients a year. Dr. Tarr's areas of interest are treatment of varicose veins and difficult diagnostic challenges. Dr. Tarr is also the President and developer of Workforce Integrity Network, a national drugtesting compliance company, and the President of DrugPak, one of the nation's leading drug testing software companies. For over 38 years of marriage, Dr. Jack Tarr and his wife, Kathy, have worked together to forge a strong team in which they share their passions for family and medicine. Leveraging their combined gifts, they have raised six children and established a successful medical practice. Jack founded Family Care Specialists in 1986 after completing family practice residency, military service and seminary training. In addition to founding and developing a ten-provider medical practice, he has consistently brought leading edge concepts into his practice and community. It is no surprise he now joins the growing number of physicians incorporating Max products into their practice. He wrote, "Patients want a choice and I have found that most want a non-pharmaceutical approach if that will help them with their quality of life issues. Max has changed my medical practice because I can finally recommend a nutritional supplement that truly impacts people and has real science behind it. Max products are the first and only supplements in over 34 years that I have recommended to my patients and I am glad to add them to my available options as a clinician. I have never seen any product, pharmaceutical or supplement, that do for the human body what the Max Products do."
y

Knoxville, TN Board Certified by The American Board of Family

y y

Practice University of Tennessee Center for Health Sciences Medical School Family Practice Residency at Naval Regional Medical Center in Jacksonville, Florida

Dr.
Owner,

Dale
Tyler

J.

Bradley,

DO,

Internal
Associates,

Medicine
Tyler, Texas

Internal

Medicine

Dr. Dale J. Bradley graduated from the Des Moines University, College Of Osteopathic Medicine and Surgery in 1994. He became a flight surgeon in the United States Air Force and attained the rank of Major. Following his time in the Air Force, he began his private practice of Internal Medicine in Tyler, Texas. A longtime proponent of nutritional and cellular health, Dr. Bradley was aware of the role of intercellular glutathione. When first introduced to MaxGXL, Dr. Bradley was skeptical that glutathione levels could be increased by an oral supplement. After a great deal of research, he and his wife decided they would try it. Within one week he and his wife experienced transformational results that he termed amazing. He then saw similar results with his extended family members. Extending its use to his patients transformed the very nature of his practice.

Dr.

Tim

Kershenstein

Dr. Kershenstein specializes in tropical and integrative medicine. He has studied Eastern Medicine which focuses on the cause, not the symptoms, of a disease. "In my opinion the West is too quick to revert to pharmaceutical drugs for treatment when the use of a natural remedy would be more appropriate and have fewer side effects." Dr. Kershenstein feels Max's glutathione enhancing products are effective remedies. He said 80 percent of people he's presented Max products to have responded quickly with definitive results. His family and friends have improved their quality of life with daily use of these products. He said that he has given them to many of his colleagues and the results have been miraculous. Referring to his background in a natural Eastern approach to healthcare, Dr. Kershenstein said that in China doctors get paid when people are well instead of sick.

Gordon

Crozier,

D.O.

OB/GYN

Division Director University of Kentucky, Morehead Women's Health Dr. Crozier received his medical degree in 1994 from Des Moines University and College of Osteopathic Medicine and Surgery. He completed his residency in Obstetrics and Gynecology in 1998 from Michigan State University, Garden City Hospital Campus. After ten years of private practice, he joined the faculty of the University of Kentucky Morehead, and in 2010 was voted the school's top educator. He was also awarded a Fellowship, Antiaging Functional and Regenerative Medicine, and is continuing his education in nutritional and metabolic medicine at the University of South Florida. He is an outspoken advocate for Max's glutathione enhancing products and their role in anti-aging and enhanced wellness.

Max International, Research Team

Herbert T. Scientist Nagasawa, Ph.D., Executive Research

Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco. Herb and the team of scientists presented their work on the cyanide antidote.

Dr.

Scott

Nagasawa,

Pharm.D.

Scott Nagasawa received his Doctor of Pharmacy degree from the University of Southern California (USC) and is also a registered pharmacist. He spent over a dozen years at a 400-plus bed tertiary teaching hospital in Los Angeles, California, affiliated with the University of Southern California. At the time of his departure, he was the Director of Pharmaceutical Services. During this period, he held the position of Clinical Instructor of Pharmacy Practice at USC and was later promoted to Adjunct Assistant Professor of Pharmacy Practice. Scott transitioned to the business side of his profession and joined a regional pharmacy as their Vice President of Pharmacy Services. He was instrumental in the planning and implementation of a strategic business plan transforming the company from a regional to a nationwide pharmacy service provider with revenues exceeding $60 million annually. At the time of his departure, he held the position of Senior Vice President of Professional Services responsible for nursing and pharmacy operations nationwide. He left to co-found a home infusion pharmacy and helped develop and implement a business plan that resulted in rapid growth to become a statewide provider. The company was sold in 2005. He remained with the company as V.P. of Operations and, at the time of his departure, the monthly revenue had grown by roughly 40 times. This revenue growth occurred over his four and a half years with the company. Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO). As CTO he was responsible for product registration, company certifications, regulatory practices, safety studies, technical sales support and the development and reviewing of product documentation.

Scott Momii, M.B.A. Executive Director of Product Management

Scott Momii was co-founder of a prominent research, development and manufacturing company for specialty chemicals. His management responsibilities included overseeing and implementation of sales and marketing programs, domestic and international purchasing, as well as customer service and accounting. He spearheaded the development and launch of three products in the areas of cosmetics (which debuted in Japan), the motion picture film industry, and a proprietary coating for high-speed ball bearings used in medical applications. He was responsible for transferring the manufacturing of a proprietary chemical from the U.S. to India. Simultaneously, he served as Director of Operations of a sister company developing biotechnology vaccines and cancer therapeutics, and specializing in pharmaceutical delivery systems based on liposomal technology. . Early in his career, he helped start a software company that developed a

UNIX-based enterprise system designed for home infusion therapy and outpatient pharmacies. He was responsible for the sales of the software to over 200 hospitals, pharmacies and five national companies. He engineered the eventual sale of the company to the largest nationwide software provider for home healthcare solutions. Mr. Momii graduated with a B.A. degree from San Jose State University, received an M.B.A. from Boston University, and completed a summer business program at Sophia University, Tokyo, Japan.